Tildrakizumab

Tildrakizumab

Common

Rarity: Common

The most frequent rarity: most Wikipedia articles become Commons.

Rarity follows how well known the article is: its views on the French and English Wikipedia over a year, and the number of languages it exists in.

At a glance

Class
Notion
Domain
Science and technology
In collections
Nobody has pulled it yet.

What Wikipedia says

Tildrakizumab, sold under the brand name Ilumya among others, is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders. It is approved for the treatment of adults with moderate-to-severe plaque psoriasis in the United States and in the European Union.

Excerpt from the Wikipedia article “Tildrakizumab”, under the CC BY-SA 4.0 license. Read the article on Wikipedia

Open free boosters and add Tildrakizumab to your collection.

Play for free

Related cards